Amgen Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amgen Inc. with three other
companies in this sector in the United States:
Gilead Sciences, Inc.
sales of $26.11 billion
of which 89%
was Antiviral products),
of which 100%
was Novel Therapeutics), and
of which 79%
Amgen Inc. reported sales of $22.85 billion
December of 2017.
decrease of 0.6%
versus 2016, when the company's sales were $22.99 billion.